Instituto de Química Avanzada de Cataluña (IQAC-CSIC)

🌲 L'IQAC-CSIC co-lidera el projecte +pinyoCAT, amb l'objectiu d'avaluar la captura de Leptoglossus Occidentalis com a eina per a minimitzar els danys sobre la producció del pi pinyer Aquest projecte, liderat pel Centre de Ciència i Tecnologia Forestal de Catalunya, vol posar a disposició del sector com fer una bona gestió productiva del pi pinyer, des de la implantació fins el maneig de la collita, considerant les característiques reproductives de l’espècie. #DemosPATT, RuralCat Gencat

📢#JobOffer We are offering a five-year postdoctoral contract to work on highly selective drug systems against cancer stem cells. The candidate, who must hold a PhD in Chemistry, Pharmacy, or a related field, will be responsible for designing molecules using computational approaches, synthesising the designed molecules, determining the photochemical properties of the molecules, evaluating biological activity in previously optimised assays with purified enzymes and studying the activity in cancer cell lines of the molecules Apply before 10th December 👉 https://bit.ly/3YV0GKz

Today, IQAC-CSIC welcomes the External Scientific Committee. 🤝 We look forward to presenting our progress and gaining valuable insights from their expert evaluation to advance the quality and impact of our work. 🔬 #WhereChemistryHelps

📊#IQACpapers: "Engineering PSMA-targeted nanoparticles co-encapsulating mitoxantrone and indocyanine green for precise combinatory therapy in prostate cancer", published in Journal of Drug Delivery Science and Technology, Elsevier Authored by researchers from Institute of Cancer Therapeutics, University of Bradford, Centre for Chemical and Biological Analysis and Instituto de Química Avanzada de Cataluña (IQAC-CSIC) 👉 https://lnkd.in/dipXZ6cV

👩🔬 Embarca't en un viatge des del més petit fins al més gran, descobrint com cada element del nostre entorn impacta a la salut humana i ambiental. 🗓️ Inscriu-te fins al 3/11 al programa Bojos per la Salut Global de la Fundació Catalunya La Pedrera 👉 bit.ly/3NfAoNL

📢#JobOffer We are seeking a #PhD student to join an ambitious and impactful project at the intersection of chemistry and biology, to develop inhibitors of FGFR3 that can be activated with external light, offering a highly selective treatment for bladder #cancer. The selected person, who will be under the supervision of Dr. Laia Josa Culleré and Dr. Amadeu Llebaria, must hold a #MSc in Chemistry, Pharmacy, or a related field 🗓️Apply before 8th November Check all the information 👉 https://bit.ly/4eTm1L1

🏆🤝 La iniciativa "QS4Dx: Kit de diagnóstico de infecciones causadas por Pseudomonas aeruginosa", presentado por Nb4D group, gana el programa de emprendimiento EBTon CSIC dotado de 20.000 euros. El proyecto es un prototipo que posibilita detectar en 10 minutos infecciones bacterianas y, de esta manera, obtener un diagnóstico del paciente más rápido y preciso. La iniciativa fue presentada por Carla Ferrero Ruedas, J.Pablo Salvador y Francesc Bejarano Badell, PhD. 👉 https://bit.ly/407Ln3x

📢 We are hiring! Are you passionate about developing innovative drugs against cancer? We are seeking a motivated PhD student to work on light-responsive drugs against bladder cancer. This is a unique opportunity if you want to master synthetic chemistry, biochemistry, cancer cell biology, photopharmacology, and molecular docking in a young and passionate group. Join us at Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) with a #JAEPRE fellowship under the project OncoLight funded by AEI/MICIU! #Photopharmacology #CancerResarch #MedChem #YoungPI

Hoy, 9 de octubre, Día Internacional de la Nanotecnología, os animamos a seguir el proyecto #ReachGlio, centrado en frenar el crecimiento de #glioblastomas mediante el uso de nanomedicinas. #ReachGlio pertenece a la convocatoria TRANSCAN 3, en el que participan siete entidades europeas, dos de ella españolas: El Instituto de Salud Carlos III (ISCIII) y el Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN). El Instituto de Química Avanzada de Cataluña (IQAC-CSIC) participa a través de los grupos CIBER-BBN de las investigadoras Ibane Abasolo y Miriam Royo Expósito. Información completa 👉 bit.ly/3NgnSgS

📊#IQACpapers: "Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis", published in International Journal of Molecular Sciences MDPI Authored by María José Gomara, Juan Camilo Sarmiento-Monroy, MD., Raul A. Castellanos Moreira MD/ Rheumatologist/ PhD, Jose A. Gómez-Puerta, Raimon Sanmartí and Isabel Haro Villar. 🔗 https://lnkd.in/eh_TMjSZ